ID   JURL-MK2
AC   CVCL_2087
SY   JURLMK2
DR   BTO; BTO:0005910
DR   CLO; CLO_0009839
DR   BioSample; SAMN03473527
DR   Cell_Model_Passport; SIDM01014
DR   CGH-DB; 9219-4
DR   DSMZ; ACC-533
DR   DSMZCellDive; ACC-533
DR   LINCS_LDP; LCL-1102
DR   Wikidata; Q54899165
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9305612;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=9305612); ~72 hours (DSMZ=ACC-533).
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=9305612; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-533
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 27,29
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 14,16
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2086 ! JURL-MK1
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 26
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=9305612; DOI=10.1038/sj.leu.2400760;
RA   Di Noto R., Luciano L., Lo Pardo C., Ferrara F., Frigeri F.,
RA   Mercuro O., Lombardi M.L., Pane F., Vacca C., Manzo C., Salvatore F.,
RA   Rotoli B., Del Vecchio L.;
RT   "JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2
RT   (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating
RT   leukemic megakaryocytopoiesis.";
RL   Leukemia 11:1554-1564(1997).
//
RX   PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4;
RA   Drexler H.G., MacLeod R.A.F., Uphoff C.C.;
RT   "Leukemia cell lines: in vitro models for the study of Philadelphia
RT   chromosome-positive leukemia.";
RL   Leuk. Res. 23:207-215(1999).
//
RX   PubMed=10576511; DOI=10.1016/s0145-2126(99)00131-9;
RA   Uphoff C.C., Habig S., Fombonne S., Matsuo Y., Drexler H.G.;
RT   "ABL-BCR expression in BCR-ABL-positive human leukemia cell lines.";
RL   Leuk. Res. 23:1055-1060(1999).
//